Optipharm.CO.LTD (153710) — Capital Reinvestment Ratio
Optipharm.CO.LTD (153710) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩315.25 Million) in capital expenditures (₩97.26 Million). See 153710 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Optipharm.CO.LTD Capital Reinvestment Ratio (2016–2019)
This chart tracks Optipharm.CO.LTD's Capital Reinvestment Ratio across 4 annual periods. Check Optipharm.CO.LTD total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Optipharm.CO.LTD (2016–2019)
Year-by-year Capital Reinvestment Ratio for Optipharm.CO.LTD from 2016 to 2019. For live market cap and broader valuation context, see 153710 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.40x | ₩447.47 Million | ₩626.46 Million | ▲ +730.3% |
| 2018 | 0.17x | ₩1.20 Billion | ₩202.91 Million | ▼ -93.4% |
| 2017 | 2.57x | ₩260.86 Million | ₩670.33 Million | ▲ +464.7% |
| 2016 | 0.46x | ₩861.36 Million | ₩391.95 Million | — |